HomeALXO • NASDAQ
add
ALX Oncology Holdings Inc
Previous close
$1.38
Day range
$1.35 - $1.43
Year range
$0.41 - $2.26
Market cap
77.26M USD
Avg Volume
360.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 22.53M | -30.81% |
Net income | -22.14M | 27.89% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -22.38M | 30.81% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 60.63M | -59.19% |
Total assets | 82.72M | -55.46% |
Total liabilities | 37.92M | -22.46% |
Total equity | 44.80M | — |
Shares outstanding | 54.22M | — |
Price to book | 1.64 | — |
Return on assets | -63.28% | — |
Return on capital | -79.90% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -22.14M | 27.89% |
Cash from operations | -17.09M | 32.64% |
Cash from investing | 21.39M | -16.74% |
Cash from financing | -159.00K | -163.35% |
Net change in cash | 4.14M | 628.87% |
Free cash flow | -3.95M | 73.86% |
About
Founded
2015
Headquarters
Website
Employees
44
